Predictive factors of septic shock and mortality in neutropenic patients

References

• Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 1998;41(suppl D):13–24.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeuriginosa infection in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000; 19:915–925.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Lyman CH, Agboola O. For the ANC study group risk models for predicting chemotherapy-induced neutropenia. Oncologist 2005;10:427–437.
   Google Scholar
• Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Chin Chem 2004;1301–1314: 50–58.
   Google Scholar
• Angus DC, Linde-Zwirble WJ, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29: 1303–1310.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Drucker M, Konigsberger H, Samra Z, Harrari S, Ashkenazi S, Pitlik SD. Septic shock in bacteremic patients: Risk factors, features and prognosis scand. J Infect Dis 1997; 29:71–75.
   Google Scholar
• Fall PJ, Szerlip HM. Lactic acidosis: From sour milk to septic shock. J Intensive Care Med 2005;20(5):255–271.
   PubMedGoogle Scholar
• Luft FC. Lactic acidosis update for critical care clinicians. Am Soc Nephro 2001;12:515–519.
   PubMed Web of Science ®Google Scholar
• Rivers EP, McIntyre L, Morro DC, Rivers KK. Early and innovative interventions for severe sepsis and septic shock: Taking advantage of a window of opportunity. CMAJ 2005; 173(9):1054–1065.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra TH, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Chin Infect Dis 2002;34:730–751.
   PubMed Web of Science ®Google Scholar
• Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees IK, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Result of MRC AML 10 trial UK Medical Research Council adult and children's leukaemia working parties. Lancet 1998; 351 (9104):700–708.
   PubMed Web of Science ®Google Scholar
• Levy MM, Flink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS in inter-national sepsis definitions conference. Crit Care Med 2003;31: 1250–1256.
   PubMed Web of Science ®Google Scholar
• American College of Chest Physician/Society of Critical Care Medicine Consensus conference: Definition for sepsis and organ failure guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–874.
   PubMed Web of Science ®Google Scholar
• Baxter F. MD, CCFP, FRCPC.septic shock. Can J Anaesth 1997;44(1):59–72.
   PubMedGoogle Scholar
• Aledo A, Heller G, Ren L, Gardner Sh, Dunkel I, McKay SW. Septicaemia and septic shock in paediatric patients: 140 consecutives cases on a paediatric haematology-oncology service. J Pediatr Hematol Oncol 1998;20(3):215–221.
   PubMed Web of Science ®Google Scholar
• Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials. Chin Infect Dis 1997;(25):247–259.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Chin Infect Dis 2003;36:1103–1110.
   PubMed Web of Science ®Google Scholar
• Penack O, Beinert T, Buchheidt D, Einsele H, Hebart H, Kiehl MG, et al. Management of sepsis in neutropenia: Guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2006;85:424–433.
   PubMed Web of Science ®Google Scholar
• Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent JL. Blood lactate levels are better prognostic indicator than TNF and IL6 levels in patients with septic shock. Intensive Care Med 1996;22(5):404–408.
   PubMed Web of Science ®Google Scholar
• Park M, Azevedo LC, Maciel AT, Pizzo VR, Noritomi DT, da Cruz Neto LM. Evolutive standard base excess and serum lactate level in severe sepsis and septic shock patients resuscitated with early goal-directed therapy: Still outcome markers? Clinics 2006;61(1):47–52.
   Google Scholar
• Dugas MA, Proulx F, de Jaeger A, Lacroix J, Lambert M. Markers of tissue hypoperfusion in paediatric sepsis shock. Intensive Care Med 2000;26(1):75–83, January.
   PubMed Web of Science ®Google Scholar
• Tuchshmidt J, Fried J, Swinney R, Sharma OP. Early hemodynamic correlates of survival in septic shock. Crit Care Med 1989;17:719–723.
   PubMed Web of Science ®Google Scholar
• Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate pyruvate and arterial ketones body ratio in the early of catecholamine-treated septic shock. Crit Care Med 2000;28:114–119.
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–1554.
   PubMed Web of Science ®Google Scholar
• Benoit DD, Vandewoude KH, Decryenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003;31:104–112.
   Google Scholar
• Stacpoole PW, Wright EC, Baumgartner TG, et al. Natural history and course of acquired lactic acidosis in adults. DCA-Lactic acidosis study group. Am J Med 1994;97:47–54.
   Google Scholar
• Gonzales Barca E, Fernadez-Sevilla A, Catarrala J, Salar A, Penis J, Granena A, Gudiol F. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteraemia. Eur J Chin Microbiol Infect Dis 1999;18(8):539–544.
   PubMed Web of Science ®Google Scholar
• Duke TD, Butt W, South M. Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997;23:684–692.
   Google Scholar
• Link H, Maschmeyer G, Meyer P, Hiddeman W, Stille W, Helmerking M, Adam D. Interventional antimicrobial therapy in febrile neutropenic patients. Study group of the Paul Ehrlich society for chemotherapy. Ann Hematol 1994;(69): 231–243.
   PubMed Web of Science ®Google Scholar
• Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985; 145:1621–1629.
   Google Scholar
• Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med 2000;160: 501–509.
   PubMed Web of Science ®Google Scholar
• Lundberg JS, Perl TM, Wiblin T, Costigan MD, Dawson J, Nettleman MD, et al. Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Grit Care Med 1998;26:1020–1024.
   PubMed Web of Science ®Google Scholar
• Engoren M. The effect of physician visits on intensive care unit mortality and cost. Grit Care Med 2005;33:727–732.
   PubMed Web of Science ®Google Scholar
• Rivers E, Ngyuyen B, Havstad S, Bessler J, Muzzin A, Knoblick B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345: 1368–1377.
   PubMed Web of Science ®Google Scholar
• Svaldi M, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001;115:53–57.
   PubMed Web of Science ®Google Scholar